European Commission (EC) is imposing financial penalties on Indian firms who export antibiotics to Europe. The move follows claims by native drug makers that the imports, which are heavily subsidised by theEC, are damaging the industry. The EC announced on Thursday 11 June that it is setting a provisional anti-subsidy duty of up to 14% on imports of the antibiotics amoxicillin trihydrate,ampicillin trihydrate and cefalexin.